David Oxlade joins TransScrip Partners

Published: 23-Dec-2009


Pharmaceutical developer TranScrip Partners recently appointed David Oxlade to the position of chairman. Oxlade is a former chief executive of biotech Xenova and in 2006 was appointed chairman of BioAnaLab, the analytical service organisation acquired in 2009 by Millipore Corporation. He also spent 14 years working for Boehringer Mannheim and a further seven serving as president of California-based, Hoechst subsidiary Syva.

You may also like